Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France:: 2003-2006

被引:41
作者
Barin, Francis
Cazein, Francoise
Lot, Florence
Pillonel, Josiane
Brunet, Sylvie
Thierry, Damien
Damond, Florence
Brun-Vezinet, Francoise
Desenclos, Jean-Claude
Semaille, Caroline
机构
[1] Univ Tours, CHU Bretonneau, Ctr Natl Reference VIH, Inserm ERI 19, F-37044 Tours, France
[2] Inst Veille Sanitaire, St Maurice, France
[3] Hop Bichat Claude Bernard, Virol Lab, F-75877 Paris 18, France
关键词
D O I
10.1097/QAD.0b013e3282f15637
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
French national surveillance of new HIV diagnoses included the collection of dried serum spots to identify HIV serotypes. Between January 2003 and June 2006, 10 184 new diagnoses were reported. The proportions of HIV-2 and HIV-1 group 0 infections were 1.8 and 0.1%, respectively. Most of these cases occurred in patients infected through heterosexual contact and originated from the corresponding endemic areas. Three cases of HIV-2 infections were reported in non-African men having sex with men.
引用
收藏
页码:2351 / 2353
页数:3
相关论文
共 22 条
[1]   FINE SEROTYPING OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROTYPE-1 (HIV-1) AND HIV-2 INFECTIONS BY USING SYNTHETIC OLIGOPEPTIDES REPRESENTING AN IMMUNODOMINANT DOMAIN OF HIV-1 AND HIV-2 SIMIAN IMMUNODEFICIENCY VIRUS [J].
BAILLOU, A ;
JANVIER, B ;
LEONARD, G ;
DENIS, F ;
GOUDEAU, A ;
BARIN, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (07) :1387-1391
[2]  
BARIN F, 1985, LANCET, V2, P1387
[3]   Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic [J].
Barin, Francis ;
Plantier, Jean-Christophe ;
Brand, Denys ;
Brunet, Sylvie ;
Moreau, Alain ;
Liandier, Benoit ;
Thierry, Damien ;
Cazein, Francoise ;
Lot, Florence ;
Semaille, Caroline ;
Desenclos, Jean-Claude .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 :S13-S18
[4]  
Berry N, 1998, J Hum Virol, V1, P457
[5]  
Brand D, 2004, AIDS, V18, P2425
[6]   ISOLATION OF A NEW HUMAN RETROVIRUS FROM WEST-AFRICAN PATIENTS WITH AIDS [J].
CLAVEL, F ;
GUETARD, D ;
BRUNVEZINET, F ;
CHAMARET, S ;
REY, MA ;
SANTOSFERREIRA, MO ;
LAURENT, AG ;
DAUGUET, C ;
KATLAMA, C ;
ROUZIOUX, C ;
KLATZMANN, D ;
CHAMPALIMAUD, JL ;
MONTAGNIER, L .
SCIENCE, 1986, 233 (4761) :343-346
[7]   Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors [J].
Damond, F ;
Brun-Vezinet, F ;
Matheron, S ;
Peytavin, G ;
Campa, P ;
Pueyo, S ;
Mammano, F ;
Lastere, S ;
Farfara, I ;
Simon, F ;
Chene, G ;
Descamps, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :484-487
[8]   Variability of human immunodeficiency virus type 2 (HIV-2) infecting patients living in France [J].
Damond, F ;
Apetrei, C ;
Robertson, DL ;
Souquière, S ;
Leprêtre, A ;
Matheron, S ;
Plantier, JC ;
Brun-Vézinet, F ;
Simon, F .
VIROLOGY, 2001, 280 (01) :19-30
[9]  
DESCAMPS D, 1997, J VIROL, V71, P8890
[10]   Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa [J].
Dougan, S ;
Patel, B ;
Tosswill, JH ;
Sinka, K .
SEXUALLY TRANSMITTED INFECTIONS, 2005, 81 (04) :338-341